about
Content analysis of oncology-related pharmaceutical advertising in a peer-reviewed medical journalImmunohistochemical profile for unknown primary adenocarcinoma.Adaptive clinical trials for new drug applications in Japan.Sample size calculation through the incorporation of heteroscedasticity and dependence for a penalized t-statistic in microarray experiments.A dose-finding approach based on shrunken predictive probability for combinations of two agents in phase I trials.An adaptive dose-finding approach for correlated bivariate binary and continuous outcomes in phase I oncology trials.
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Akihiro Hirakawa
@ast
Akihiro Hirakawa
@en
Akihiro Hirakawa
@es
Akihiro Hirakawa
@nl
Akihiro Hirakawa
@sl
type
label
Akihiro Hirakawa
@ast
Akihiro Hirakawa
@en
Akihiro Hirakawa
@es
Akihiro Hirakawa
@nl
Akihiro Hirakawa
@sl
prefLabel
Akihiro Hirakawa
@ast
Akihiro Hirakawa
@en
Akihiro Hirakawa
@es
Akihiro Hirakawa
@nl
Akihiro Hirakawa
@sl
P106
P21
P31
P496
0000-0002-1193-8104
P569
2000-01-01T00:00:00Z